Physician profile
Eric S Stem
NPI 1831100064
$5,764.54
in general payments reported to CMS, 2019-2025
23 companies · $456 in 2025
The $456 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,368 · 2020: $1,127 · 2021: $130 · 2022: $255 · 2023: $1,877 · 2024: $551 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,901 · Travel and Lodging: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,900.58 |
| Travel and Lodging | $983.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $1,195.10 | 2020-2022 | |
| Medtronic USA, INC. | $1,005.30 | 2019 | |
| Peerless Surgical INC. | $887.68 | 2019-2024 | |
| Stryker Corporation | $695.63 | 2019-2025 | Mako, Triathlon, Aequalis Ascend Flex |
| Ferring Pharmaceuticals INC. | $596.77 | 2022-2025 | Euflexxa |
| Exactech, INC. | $311.94 | 2022-2023 | |
| Arthrex, INC. | $278.08 | 2023 | |
| Zimmer Biomet Holdings, INC. | $198.32 | 2024 | Oss Orthopedic Salvage System |
| Heron Therapeutics, INC. | $79.89 | 2023-2025 | Zynrelef |
| Ermi LLC | $65.71 | 2019-2023 | |
| Abbott Laboratories | $60.99 | 2021-2023 | Axium, Penta |
| Fidia Pharma USA INC. | $53.56 | 2024 | Hym/Hyn |
| Depuy Synthes Sales INC. | $51.30 | 2024-2025 | Monovisc, Orthovisc |
| Orthogenrx INC. | $49.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $46.18 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $36.22 | 2021-2024 | |
| Amgen INC. | $30.79 | 2019 | |
| Medical Device Business Services, INC. | $29.08 | 2023 | Inhance |
| Pacira Therapeutics, INC. | $23.13 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.25 | 2019 | |
| Horizon Therapeutics Plc | $17.71 | 2019 | |
| Nalu Medical, INC. | $16.54 | 2025 | Nalu Neurostimulation System |
| Zyla Life Sciences, INC. | $16.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Stem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.